Agilent Pharmaceutical Structure Confirmation Using Mass Spectrometry Nuclear Magnetic Resonance Spectroscopy Applicatio

This document investigates the structure of clindamycin using mass spectrometry and nuclear magnetic resonance spectroscopy. The data allows for the rapid confirmation of the chemical structure.


Agilent Pharmaceutical Structure Confirmation Using Mass Spectrometry Nuclear Magnetic Resonance Spectroscopy Applicatio - cover page
Brand
Agilent
Document type
Application Note
Language
English
Pages
4
File format
PDF
File size
188 KB
Published
11 June, 2012
Updated
28 September, 2023
MD5 checksum
08AFCCC95E8428BB2773D15BF6528EB7

About this manual

This document investigates the chemical structure of clindamycin, a widely prescribed antibiotic, by integrating mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR). The study utilizes an Agilent 500 Ion Trap LC/MS system and an Agilent 400-MR NMR spectrometer to provide complementary structural information.

What's inside

  • Introduction
  • Results and Discussion
  • Primary mass spectral investigations
  • NMR spectra interpretation
  • Structural fragment analysis
  • Conclusion

Frequently asked questions

What chemical structure does this application note investigate?

The document investigates the structure of clindamycin.

Which instruments were used to confirm the structure of clindamycin?

An Agilent 500 Ion Trap LC/MS and an Agilent 400-MR NMR spectrometer were used.

What is the protonated molecule signal for clindamycin in the mass spectrum?

The analyte displayed a signal representing the protonated molecule at m/z 425.2.

Download PDF (188 KB)

More Agilent Manuals


View all Agilent manuals →